Sakari Vanharanta
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
BCL-XL Dependence is a Subtype Agnostic Actionable Feature of Difficult-to-Treat Kidney Cancers.
Journal: bioRxiv : the preprint server for biology
Published: December 19, 2025
Oriented binding of transcription factors to nucleosomes remodels chromatin at human promoters.
Journal: Molecular cell
Published: September 29, 2025
Tumour sampling conditions perturb the metabolic landscape of clear cell renal cell carcinoma.
Journal: Nature communications
Published: August 04, 2025
Mechanisms of resistance to VHL loss-induced genetic and pharmacological vulnerabilities.
Journal: EMBO molecular medicine
Published: June 13, 2025
Tumor cell FAP orchestrates EMT and immune suppression in aggressive localized ccRCC.
Journal: Theranostics
Published: May 28, 2025
The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs.
Journal: Nature communications
Published: September 14, 2024
Cancer cells impair monocyte-mediated T cell stimulation to evade immunity.
Journal: Nature
Published: September 01, 2023
The SWI/SNF complex member SMARCB1 supports lineage fidelity in kidney cancer.
Journal: iScience
Published: March 28, 2023
Cancer Cell-Derived PDGFB Stimulates mTORC1 Activation in Renal Carcinoma.
Journal: International journal of molecular sciences
Published: November 26, 2022
Dynamic partitioning of branched-chain amino acids-derived nitrogen supports renal cancer progression.
Journal: Nature communications
Published: October 20, 2021
Last Updated: 09/26/2026